Longeveron (LGVN) Change in Cash (2020 - 2026)
Longeveron's (LGVN) quarterly Change in Cash came in at $11.1 million in Q1 2026, up 326.24% year-on-year from $2.6 million in Q1 2025, and up 342.13% quarter-over-quarter from -$4.6 million in Q4 2025.
Longeveron (LGVN) Change in Cash (2020 - 2026) Analysis & Trends
Longeveron's Change in Cash history runs 7 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- On a quarterly basis, Change in Cash rose 326.24% year-over-year to $11.1 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 88.45% decrease from a year earlier, with the FY2025 full-year figure at -$14.6 million, down 202.02% from the prior year.
- Change in Cash advanced to $11.1 million in Q1 2026 per LGVN's latest filing, from -$4.6 million in the prior quarter.
- Across five years, Change in Cash topped out at $11.1 million in Q1 2026 and bottomed at -$6.6 million in Q3 2022.
- The 5-year median for Change in Cash is -$3.0 million (2024), against an average of -$582352.9.
- Biggest YoY gain for Change in Cash was 1433.72% in 2024; the steepest drop was 218.91% in 2024.
- Year by year, Change in Cash stood at -$3.1 million in 2022, then jumped by 197.1% to $3.0 million in 2023, then plunged by 218.91% to -$3.5 million in 2024, then dropped by 29.24% to -$4.6 million in 2025, then soared by 342.13% to $11.1 million in 2026.
- Per Business Quant, the three latest LGVN Change in Cash figures stand at $11.1 million (Q1 2026), -$4.6 million (Q4 2025), and -$1.1 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 | 11.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.10 Mn |
| Dec 31, 2025 | -4.58 Mn |
| Sep 30, 2025 | -1.09 Mn |
| Jun 30, 2025 | -3.99 Mn |
| Mar 31, 2025 | -4.91 Mn |
| Dec 31, 2024 | -3.55 Mn |
| Sep 30, 2024 | 10.40 Mn |
| Jun 30, 2024 | 10.44 Mn |
| Mar 31, 2024 | -3.01 Mn |
| Dec 31, 2023 | 2.98 Mn |
| Sep 30, 2023 | -780,000.00 |
| Jun 30, 2023 | -2.24 Mn |
| Mar 31, 2023 | -5.52 Mn |
| Dec 31, 2022 | -3.07 Mn |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | -1.91 Mn |
| Mar 31, 2022 | -3.53 Mn |
| Dec 31, 2021 | 15.92 Mn |
| Sep 30, 2021 | -7.10 Mn |
| Jun 30, 2021 | -7.63 Mn |